Prevalence Rate of Adverse Drug Reactions from Sodium-Glucose Cotransporter-2 Inhibitors: A Retrospective Cohort Study
Abstract
Share and Cite
Srimaya, P.; Warong, T.; Kingdang, S.; Pradubkham, T.; Phimarn, W. Prevalence Rate of Adverse Drug Reactions from Sodium-Glucose Cotransporter-2 Inhibitors: A Retrospective Cohort Study. Pharmacoepidemiology 2026, 5, 2. https://doi.org/10.3390/pharma5010002
Srimaya P, Warong T, Kingdang S, Pradubkham T, Phimarn W. Prevalence Rate of Adverse Drug Reactions from Sodium-Glucose Cotransporter-2 Inhibitors: A Retrospective Cohort Study. Pharmacoepidemiology. 2026; 5(1):2. https://doi.org/10.3390/pharma5010002
Chicago/Turabian StyleSrimaya, Pichitra, Tossapol Warong, Sudarat Kingdang, Titawadee Pradubkham, and Wiraphol Phimarn. 2026. "Prevalence Rate of Adverse Drug Reactions from Sodium-Glucose Cotransporter-2 Inhibitors: A Retrospective Cohort Study" Pharmacoepidemiology 5, no. 1: 2. https://doi.org/10.3390/pharma5010002
APA StyleSrimaya, P., Warong, T., Kingdang, S., Pradubkham, T., & Phimarn, W. (2026). Prevalence Rate of Adverse Drug Reactions from Sodium-Glucose Cotransporter-2 Inhibitors: A Retrospective Cohort Study. Pharmacoepidemiology, 5(1), 2. https://doi.org/10.3390/pharma5010002

